APO Research
Talk to an analyst

APO RESEARCH · REPORT

Defibrinated Horse Blood

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Defibrinated Horse Blood Industry Growth and Trends Forecast to 2032

8 January 2026122 pages

Choose your research edition.

Industry ResearchDefibrinated Horse Blood Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Defibrinated Horse Blood Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Defibrinated Horse Blood Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Defibrinated Horse Blood Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Defibrinated Horse Blood Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Defibrinated Horse Blood market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Defibrinated Horse Blood is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Defibrinated Horse Blood is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Defibrinated Horse Blood is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Defibrinated Horse Blood include Thermo Fisher Scientific, TCS Biosciences, BioMérieux, E & O Laboratories Ltd, Southern Biological, Biowest(BioNordic A/S), Pel-Freez Biologicals, Trafalgar Scientific and HemoStat Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Defibrinated Horse Blood market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Defibrinated Horse Blood market size, estimates, and forecasts are presented in terms of sales volume (kL) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Defibrinated Horse Blood market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Defibrinated Horse Blood.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Defibrinated Horse Blood market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Defibrinated Horse Blood Market by Company

Thermo Fisher Scientific

TCS Biosciences

BioMérieux

E & O Laboratories Ltd

Southern Biological

Biowest(BioNordic A/S)

Pel-Freez Biologicals

Trafalgar Scientific

HemoStat Laboratories

EWC Diagnostics

Dutscher

Serana Europe

Kraeber & Co. GmbH

Bio Nutrientes Do Brasil Ltda.

Lampire Biological Laboratories, Inc.

Innovative Research Inc

Colorado Serum

SSI Diagnostica

SR Group

Szabo-Scandic

Rockland Immunochemicals, Inc.

LABone Scientific Co.Ltd.

Quad Five(Materials Bio Inc.)

Guangzhou Ruite Biotechnology Co., Ltd.

Obio Technology (Shanghai) Corp., Ltd.

Beijing Solarbio Science & Technology Co.,Ltd.

Nanjing SenBeiJia Biological Technology Co., Ltd.

Defibrinated Horse Blood Segment by Type

50ml

100ml

250ml

500ml

Others

Defibrinated Horse Blood Segment by Application

Biomedicine

Research

Defibrinated Horse Blood Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Defibrinated Horse Blood market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Defibrinated Horse Blood and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Defibrinated Horse Blood.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Defibrinated Horse Blood manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Defibrinated Horse Blood in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 50ml Table 2. Major Company of 100ml Table 3. Major Company of 250ml Table 4. Major Company of 500ml Table 5. Major Company of Others Table 6. Global Defibrinated Horse Blood Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Defibrinated Horse Blood Sales by Type (2021-2026) & (kL) Table 8. Global Defibrinated Horse Blood Sales Market Share in Volume by Type (2021-2026) Table 9. Global Defibrinated Horse Blood Sales by Type (2021-2026) & (US$ Million) Table 10. Global Defibrinated Horse Blood Sales Market Share in Value by Type (2021-2026) Table 11. Global Defibrinated Horse Blood Price by Type (2021-2026) & (USD/L) Table 12. Global Defibrinated Horse Blood Sales by Type (2027-2032) & (kL) Table 13. Global Defibrinated Horse Blood Sales Market Share in Volume by Type (2027-2032) Table 14. Global Defibrinated Horse Blood Sales by Type (2027-2032) & (US$ Million) Table 15. Global Defibrinated Horse Blood Sales Market Share in Value by Type (2027-2032) Table 16. Global Defibrinated Horse Blood Price by Type (2027-2032) & (USD/L) Table 17. North America Defibrinated Horse Blood Sales by Type (2021-2026) & (kL) Table 18. North America Defibrinated Horse Blood Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Defibrinated Horse Blood Sales by Type (2021-2026) & (kL) Table 20. Europe Defibrinated Horse Blood Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Defibrinated Horse Blood Sales by Type (2021-2026) & (kL) Table 22. Asia-Pacific Defibrinated Horse Blood Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Defibrinated Horse Blood Sales by Type (2021-2026) & (kL) Table 24. Latin America Defibrinated Horse Blood Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Defibrinated Horse Blood Sales by Type (2021-2026) & (kL) Table 26. Middle East and Africa Defibrinated Horse Blood Sales by Type (2021-2026) & (US$ Million) Table 27. Defibrinated Horse Blood Industry Trends Table 28. Defibrinated Horse Blood Industry Drivers Table 29. Defibrinated Horse Blood Industry Opportunities and Challenges Table 30. Defibrinated Horse Blood Industry Restraints Table 31. Global Defibrinated Horse Blood Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Defibrinated Horse Blood Revenue Market Share by Company (2021-2026) Table 33. Global Defibrinated Horse Blood Sales by Company (2021-2026) & (kL) Table 34. Global Defibrinated Horse Blood Sales Share by Company (2021-2026) Table 35. Global Defibrinated Horse Blood Market Price by Company (2021-2026) & (USD/L) Table 36. Global Defibrinated Horse Blood Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Defibrinated Horse Blood Major Company Production Sites and Headquarters Table 38. Global Defibrinated Horse Blood Company, Product Type & Application Table 39. Global Defibrinated Horse Blood Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Defibrinated Horse Blood by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Defibrinated Horse Blood Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Defibrinated Horse Blood Sales by Region (2021-2026) & (kL) Table 44. Global Defibrinated Horse Blood Sales Market Share in Volume by Region (2021-2026) Table 45. Global Defibrinated Horse Blood Sales by Region (2021-2026) & (US$ Million) Table 46. Global Defibrinated Horse Blood Sales Market Share in Value by Region (2021-2026) Table 47. Global Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 48. Global Defibrinated Horse Blood Sales by Region (2027-2032) & (kL) Table 49. Global Defibrinated Horse Blood Sales Market Share in Volume by Region (2027-2032) Table 50. Global Defibrinated Horse Blood Sales by Region (2027-2032) & (US$ Million) Table 51. Global Defibrinated Horse Blood Sales Market Share in Value by Region (2027-2032) Table 52. Global Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2027-2032) Table 53. Global Defibrinated Horse Blood Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Defibrinated Horse Blood Sales by Application (2021-2026) & (kL) Table 55. Global Defibrinated Horse Blood Sales Market Share in Volume by Application (2021-2026) Table 56. Global Defibrinated Horse Blood Sales by Application (2021-2026) & (US$ Million) Table 57. Global Defibrinated Horse Blood Sales Market Share in Value by Application (2021-2026) Table 58. Global Defibrinated Horse Blood Price by Application (2021-2026) & (USD/L) Table 59. Global Defibrinated Horse Blood Sales by Application (2027-2032) & (kL) Table 60. Global Defibrinated Horse Blood Sales Market Share in Volume by Application (2027-2032) Table 61. Global Defibrinated Horse Blood Sales by Application (2027-2032) & (US$ Million) Table 62. Global Defibrinated Horse Blood Sales Market Share in Value by Application (2027-2032) Table 63. Global Defibrinated Horse Blood Price by Application (2027-2032) & (USD/L) Table 64. North America Defibrinated Horse Blood Sales by Application (2021-2026) & (kL) Table 65. North America Defibrinated Horse Blood Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Defibrinated Horse Blood Sales by Application (2021-2026) & (kL) Table 67. Europe Defibrinated Horse Blood Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Defibrinated Horse Blood Sales by Application (2021-2026) & (kL) Table 69. Asia-Pacific Defibrinated Horse Blood Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Defibrinated Horse Blood Sales by Application (2021-2026) & (kL) Table 71. Latin America Defibrinated Horse Blood Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Defibrinated Horse Blood Sales by Application (2021-2026) & (kL) Table 73. Middle East and Africa Defibrinated Horse Blood Sales by Application (2021-2026) & (US$ Million) Table 74. Thermo Fisher Scientific Company Information Table 75. Thermo Fisher Scientific Business Overview Table 76. Thermo Fisher Scientific Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 77. Thermo Fisher Scientific Defibrinated Horse Blood Product Portfolio Table 78. Thermo Fisher Scientific Recent Development Table 79. TCS Biosciences Company Information Table 80. TCS Biosciences Business Overview Table 81. TCS Biosciences Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 82. TCS Biosciences Defibrinated Horse Blood Product Portfolio Table 83. TCS Biosciences Recent Development Table 84. BioMérieux Company Information Table 85. BioMérieux Business Overview Table 86. BioMérieux Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 87. BioMérieux Defibrinated Horse Blood Product Portfolio Table 88. BioMérieux Recent Development Table 89. E & O Laboratories Ltd Company Information Table 90. E & O Laboratories Ltd Business Overview Table 91. E & O Laboratories Ltd Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 92. E & O Laboratories Ltd Defibrinated Horse Blood Product Portfolio Table 93. E & O Laboratories Ltd Recent Development Table 94. Southern Biological Company Information Table 95. Southern Biological Business Overview Table 96. Southern Biological Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 97. Southern Biological Defibrinated Horse Blood Product Portfolio Table 98. Southern Biological Recent Development Table 99. Biowest(BioNordic A/S) Company Information Table 100. Biowest(BioNordic A/S) Business Overview Table 101. Biowest(BioNordic A/S) Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 102. Biowest(BioNordic A/S) Defibrinated Horse Blood Product Portfolio Table 103. Biowest(BioNordic A/S) Recent Development Table 104. Pel-Freez Biologicals Company Information Table 105. Pel-Freez Biologicals Business Overview Table 106. Pel-Freez Biologicals Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 107. Pel-Freez Biologicals Defibrinated Horse Blood Product Portfolio Table 108. Pel-Freez Biologicals Recent Development Table 109. Trafalgar Scientific Company Information Table 110. Trafalgar Scientific Business Overview Table 111. Trafalgar Scientific Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 112. Trafalgar Scientific Defibrinated Horse Blood Product Portfolio Table 113. Trafalgar Scientific Recent Development Table 114. HemoStat Laboratories Company Information Table 115. HemoStat Laboratories Business Overview Table 116. HemoStat Laboratories Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 117. HemoStat Laboratories Defibrinated Horse Blood Product Portfolio Table 118. HemoStat Laboratories Recent Development Table 119. EWC Diagnostics Company Information Table 120. EWC Diagnostics Business Overview Table 121. EWC Diagnostics Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 122. EWC Diagnostics Defibrinated Horse Blood Product Portfolio Table 123. EWC Diagnostics Recent Development Table 124. Dutscher Company Information Table 125. Dutscher Business Overview Table 126. Dutscher Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 127. Dutscher Defibrinated Horse Blood Product Portfolio Table 128. Dutscher Recent Development Table 129. Serana Europe Company Information Table 130. Serana Europe Business Overview Table 131. Serana Europe Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 132. Serana Europe Defibrinated Horse Blood Product Portfolio Table 133. Serana Europe Recent Development Table 134. Kraeber & Co. GmbH Company Information Table 135. Kraeber & Co. GmbH Business Overview Table 136. Kraeber & Co. GmbH Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 137. Kraeber & Co. GmbH Defibrinated Horse Blood Product Portfolio Table 138. Kraeber & Co. GmbH Recent Development Table 139. Bio Nutrientes Do Brasil Ltda. Company Information Table 140. Bio Nutrientes Do Brasil Ltda. Business Overview Table 141. Bio Nutrientes Do Brasil Ltda. Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 142. Bio Nutrientes Do Brasil Ltda. Defibrinated Horse Blood Product Portfolio Table 143. Bio Nutrientes Do Brasil Ltda. Recent Development Table 144. Lampire Biological Laboratories, Inc. Company Information Table 145. Lampire Biological Laboratories, Inc. Business Overview Table 146. Lampire Biological Laboratories, Inc. Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 147. Lampire Biological Laboratories, Inc. Defibrinated Horse Blood Product Portfolio Table 148. Lampire Biological Laboratories, Inc. Recent Development Table 149. Innovative Research Inc Company Information Table 150. Innovative Research Inc Business Overview Table 151. Innovative Research Inc Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 152. Innovative Research Inc Defibrinated Horse Blood Product Portfolio Table 153. Innovative Research Inc Recent Development Table 154. Colorado Serum Company Information Table 155. Colorado Serum Business Overview Table 156. Colorado Serum Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 157. Colorado Serum Defibrinated Horse Blood Product Portfolio Table 158. Colorado Serum Recent Development Table 159. SSI Diagnostica Company Information Table 160. SSI Diagnostica Business Overview Table 161. SSI Diagnostica Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 162. SSI Diagnostica Defibrinated Horse Blood Product Portfolio Table 163. SSI Diagnostica Recent Development Table 164. SR Group Company Information Table 165. SR Group Business Overview Table 166. SR Group Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 167. SR Group Defibrinated Horse Blood Product Portfolio Table 168. SR Group Recent Development Table 169. Szabo-Scandic Company Information Table 170. Szabo-Scandic Business Overview Table 171. Szabo-Scandic Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 172. Szabo-Scandic Defibrinated Horse Blood Product Portfolio Table 173. Szabo-Scandic Recent Development Table 174. Rockland Immunochemicals, Inc. Company Information Table 175. Rockland Immunochemicals, Inc. Business Overview Table 176. Rockland Immunochemicals, Inc. Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 177. Rockland Immunochemicals, Inc. Defibrinated Horse Blood Product Portfolio Table 178. Rockland Immunochemicals, Inc. Recent Development Table 179. LABone Scientific Co.Ltd. Company Information Table 180. LABone Scientific Co.Ltd. Business Overview Table 181. LABone Scientific Co.Ltd. Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 182. LABone Scientific Co.Ltd. Defibrinated Horse Blood Product Portfolio Table 183. LABone Scientific Co.Ltd. Recent Development Table 184. Quad Five(Materials Bio Inc.) Company Information Table 185. Quad Five(Materials Bio Inc.) Business Overview Table 186. Quad Five(Materials Bio Inc.) Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 187. Quad Five(Materials Bio Inc.) Defibrinated Horse Blood Product Portfolio Table 188. Quad Five(Materials Bio Inc.) Recent Development Table 189. Guangzhou Ruite Biotechnology Co., Ltd. Company Information Table 190. Guangzhou Ruite Biotechnology Co., Ltd. Business Overview Table 191. Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 192. Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Horse Blood Product Portfolio Table 193. Guangzhou Ruite Biotechnology Co., Ltd. Recent Development Table 194. Obio Technology (Shanghai) Corp., Ltd. Company Information Table 195. Obio Technology (Shanghai) Corp., Ltd. Business Overview Table 196. Obio Technology (Shanghai) Corp., Ltd. Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 197. Obio Technology (Shanghai) Corp., Ltd. Defibrinated Horse Blood Product Portfolio Table 198. Obio Technology (Shanghai) Corp., Ltd. Recent Development Table 199. Beijing Solarbio Science & Technology Co.,Ltd. Company Information Table 200. Beijing Solarbio Science & Technology Co.,Ltd. Business Overview Table 201. Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 202. Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Horse Blood Product Portfolio Table 203. Beijing Solarbio Science & Technology Co.,Ltd. Recent Development Table 204. Nanjing SenBeiJia Biological Technology Co., Ltd. Company Information Table 205. Nanjing SenBeiJia Biological Technology Co., Ltd. Business Overview Table 206. Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 207. Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Horse Blood Product Portfolio Table 208. Nanjing SenBeiJia Biological Technology Co., Ltd. Recent Development Table 209. North America Defibrinated Horse Blood Market Size Growth Rate (CAGR) by Country (kL): 2021 VS 2025 VS 2032 Table 210. North America Defibrinated Horse Blood Sales by Country (2021-2026) & (kL) Table 211. North America Defibrinated Horse Blood Sales Market Share by Country (2021-2026) Table 212. North America Defibrinated Horse Blood Sales Forecast by Country (2027-2032) & (kL) Table 213. North America Defibrinated Horse Blood Sales Market Share Forecast by Country (2027-2032) Table 214. North America Defibrinated Horse Blood Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 215. North America Defibrinated Horse Blood Market Size by Country (2021-2026) & (US$ Million) Table 216. North America Defibrinated Horse Blood Market Share by Country (2021-2026) Table 217. North America Defibrinated Horse Blood Market Size Forecast by Country (2027-2032) & (US$ Million) Table 218. North America Defibrinated Horse Blood Market Share Forecast by Country (2027-2032) Table 219. Europe Defibrinated Horse Blood Market Size Growth Rate (CAGR) by Country (kL): 2021 VS 2025 VS 2032 Table 220. Europe Defibrinated Horse Blood Sales by Country (2021-2026) & (kL) Table 221. Europe Defibrinated Horse Blood Sales Market Share by Country (2021-2026) Table 222. Europe Defibrinated Horse Blood Sales Forecast by Country (2027-2032) & (kL) Table 223. Europe Defibrinated Horse Blood Sales Market Share Forecast by Country (2027-2032) Table 224. Europe Defibrinated Horse Blood Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 225. Europe Defibrinated Horse Blood Market Size by Country (2021-2026) & (US$ Million) Table 226. Europe Defibrinated Horse Blood Market Share by Country (2021-2026) Table 227. Europe Defibrinated Horse Blood Market Size Forecast by Country (2027-2032) & (US$ Million) Table 228. Europe Defibrinated Horse Blood Market Share Forecast by Country (2027-2032) Table 229. Asia-Pacific Defibrinated Horse Blood Market Size Growth Rate (CAGR) by Country (kL): 2021 VS 2025 VS 2032 Table 230. Asia-Pacific Defibrinated Horse Blood Sales by Country (2021-2026) & (kL) Table 231. Asia-Pacific Defibrinated Horse Blood Sales Market Share by Country (2021-2026) Table 232. Asia-Pacific Defibrinated Horse Blood Sales Forecast by Country (2027-2032) & (kL) Table 233. Asia-Pacific Defibrinated Horse Blood Sales Market Share Forecast by Country (2027-2032) Table 234. Asia-Pacific Defibrinated Horse Blood Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 235. Asia-Pacific Defibrinated Horse Blood Market Size by Country (2021-2026) & (US$ Million) Table 236. Asia-Pacific Defibrinated Horse Blood Market Share by Country (2021-2026) Table 237. Asia-Pacific Defibrinated Horse Blood Market Size Forecast by Country (2027-2032) & (US$ Million) Table 238. Asia-Pacific Defibrinated Horse Blood Market Share Forecast by Country (2027-2032) Table 239. Latin America Defibrinated Horse Blood Market Size Growth Rate (CAGR) by Country (kL): 2021 VS 2025 VS 2032 Table 240. Latin America Defibrinated Horse Blood Sales by Country (2021-2026) & (kL) Table 241. Latin America Defibrinated Horse Blood Sales Market Share by Country (2021-2026) Table 242. Latin America Defibrinated Horse Blood Sales Forecast by Country (2027-2032) & (kL) Table 243. Latin America Defibrinated Horse Blood Sales Market Share Forecast by Country (2027-2032) Table 244. Latin America Defibrinated Horse Blood Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 245. Latin America Defibrinated Horse Blood Market Size by Country (2021-2026) & (US$ Million) Table 246. Latin America Defibrinated Horse Blood Market Share by Country (2021-2026) Table 247. Latin America Defibrinated Horse Blood Market Size Forecast by Country (2027-2032) & (US$ Million) Table 248. Latin America Defibrinated Horse Blood Market Share Forecast by Country (2027-2032) Table 249. Middle East and Africa Defibrinated Horse Blood Market Size Growth Rate (CAGR) by Country (kL): 2021 VS 2025 VS 2032 Table 250. Middle East and Africa Defibrinated Horse Blood Sales by Country (2021-2026) & (kL) Table 251. Middle East and Africa Defibrinated Horse Blood Sales Market Share by Country (2021-2026) Table 252. Middle East and Africa Defibrinated Horse Blood Sales Forecast by Country (2027-2032) & (kL) Table 253. Middle East and Africa Defibrinated Horse Blood Sales Market Share Forecast by Country (2027-2032) Table 254. Middle East and Africa Defibrinated Horse Blood Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 255. Middle East and Africa Defibrinated Horse Blood Market Size by Country (2021-2026) & (US$ Million) Table 256. Middle East and Africa Defibrinated Horse Blood Market Share by Country (2021-2026) Table 257. Middle East and Africa Defibrinated Horse Blood Market Size Forecast by Country (2027-2032) & (US$ Million) Table 258. Middle East and Africa Defibrinated Horse Blood Market Share Forecast by Country (2027-2032) Table 259. Key Raw Materials Table 260. Raw Materials Key Suppliers Table 261. Defibrinated Horse Blood Distributors List Table 262. Defibrinated Horse Blood Customers List Table 263. Research Programs/Design for This Report Table 264. Authors List of This Report Table 265. Secondary Sources Table 266. Primary Sources List of Figures Figure 1. Defibrinated Horse Blood Image Figure 2. Global Defibrinated Horse Blood Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Defibrinated Horse Blood Market Size (2021-2032) & (US$ Million) Figure 4. Global Defibrinated Horse Blood Sales (2021-2032) & (kL) Figure 5. 50ml Image Figure 6. Global 50ml Sales YoY Growth (2021-2032) & (kL) Figure 7. 100ml Image Figure 8. Global 100ml Sales YoY Growth (2021-2032) & (kL) Figure 9. 250ml Image Figure 10. Global 250ml Sales YoY Growth (2021-2032) & (kL) Figure 11. 500ml Image Figure 12. Global 500ml Sales YoY Growth (2021-2032) & (kL) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (kL) Figure 15. Global Defibrinated Horse Blood Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Defibrinated Horse Blood Market Share by Type 2025 VS 2032 Figure 17. North America Defibrinated Horse Blood Sales Market Share in Volume by Type in 2025 Figure 18. North America Defibrinated Horse Blood Sales Market Share in Value by Type in 2025 Figure 19. Europe Defibrinated Horse Blood Sales Market Share in Volume by Type in 2025 Figure 20. Europe Defibrinated Horse Blood Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Defibrinated Horse Blood Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Defibrinated Horse Blood Sales Market Share in Value by Type in 2025 Figure 23. Latin America Defibrinated Horse Blood Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Defibrinated Horse Blood Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Defibrinated Horse Blood Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Defibrinated Horse Blood Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Defibrinated Horse Blood Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Biomedicine Image Figure 30. Global Biomedicine Sales YoY Growth (2021-2032) & (kL) Figure 31. Research Image Figure 32. Global Research Sales YoY Growth (2021-2032) & (kL) Figure 33. Global Defibrinated Horse Blood Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Defibrinated Horse Blood Market Share by Application 2025 VS 2032 Figure 35. North America Defibrinated Horse Blood Sales Market Share in Volume by Application in 2025 Figure 36. North America Defibrinated Horse Blood Sales Market Share in Value by Application in 2025 Figure 37. Europe Defibrinated Horse Blood Sales Market Share in Volume by Application in 2025 Figure 38. Europe Defibrinated Horse Blood Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Defibrinated Horse Blood Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Defibrinated Horse Blood Sales Market Share in Value by Application in 2025 Figure 41. Latin America Defibrinated Horse Blood Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Defibrinated Horse Blood Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Defibrinated Horse Blood Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Defibrinated Horse Blood Sales Market Share in Value by Application in 2025 Figure 45. North America Defibrinated Horse Blood Sales by Country: 2021 VS 2025 VS 2032 (kL) Figure 46. North America Defibrinated Horse Blood Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Defibrinated Horse Blood Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Defibrinated Horse Blood Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Defibrinated Horse Blood Sales by Country: 2021 VS 2025 VS 2032 (kL) Figure 50. Europe Defibrinated Horse Blood Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Defibrinated Horse Blood Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Defibrinated Horse Blood Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Defibrinated Horse Blood Sales by Country: 2021 VS 2025 VS 2032 (kL) Figure 54. Asia-Pacific Defibrinated Horse Blood Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Defibrinated Horse Blood Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Defibrinated Horse Blood Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Defibrinated Horse Blood Sales by Country: 2021 VS 2025 VS 2032 (kL) Figure 58. Latin America Defibrinated Horse Blood Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Defibrinated Horse Blood Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Defibrinated Horse Blood Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Defibrinated Horse Blood Sales by Country: 2021 VS 2025 VS 2032 (kL) Figure 62. Middle East and Africa Defibrinated Horse Blood Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Defibrinated Horse Blood Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Defibrinated Horse Blood Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Defibrinated Horse Blood Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Defibrinated Horse Blood Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 50ml
  • 100ml
  • 250ml
  • 500ml
  • Others
Applications
  • Biomedicine
  • Research
Companies covered
  • Thermo Fisher Scientific
  • TCS Biosciences
  • BioMérieux
  • E & O Laboratories Ltd
  • Southern Biological
  • Biowest(BioNordic A/S)
  • Pel-Freez Biologicals
  • Trafalgar Scientific
  • HemoStat Laboratories
  • EWC Diagnostics
  • Dutscher
  • Serana Europe
  • Kraeber & Co. GmbH
  • Bio Nutrientes Do Brasil Ltda.
  • Lampire Biological Laboratories, Inc.
  • Innovative Research Inc
  • Colorado Serum
  • SSI Diagnostica
  • SR Group
  • Szabo-Scandic
  • Rockland Immunochemicals, Inc.
  • LABone Scientific Co.Ltd.
  • Quad Five(Materials Bio Inc.)
  • Guangzhou Ruite Biotechnology Co., Ltd.
  • Obio Technology (Shanghai) Corp., Ltd.
  • Beijing Solarbio Science & Technology Co.,Ltd.
  • Nanjing SenBeiJia Biological Technology Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Defibrinated Horse Blood Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Defibrinated Horse Blood Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Defibrinated Horse Blood Market by Type
  6. 1.3.1 50ml
  7. 1.3.2 100ml
  8. 1.3.3 250ml
  9. 1.3.4 500ml
  10. 1.3.5 Others
  11. 1.4 Global Defibrinated Horse Blood Market Size by Type
  12. 1.4.1 Global Defibrinated Horse Blood Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Defibrinated Horse Blood Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Defibrinated Horse Blood Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Defibrinated Horse Blood Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Defibrinated Horse Blood Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Defibrinated Horse Blood Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Defibrinated Horse Blood Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Defibrinated Horse Blood Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Defibrinated Horse Blood Industry Trends
  2. 2.2 Defibrinated Horse Blood Industry Drivers
  3. 2.3 Defibrinated Horse Blood Industry Opportunities and Challenges
  4. 2.4 Defibrinated Horse Blood Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Defibrinated Horse Blood Revenue (2021-2026)
  2. 3.2 Global Top Players by Defibrinated Horse Blood Sales (2021-2026)
  3. 3.3 Global Top Players by Defibrinated Horse Blood Price (2021-2026)
  4. 3.4 Global Defibrinated Horse Blood Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Defibrinated Horse Blood Major Company Production Sites & Headquarters
  6. 3.6 Global Defibrinated Horse Blood Company, Product Type & Application
  7. 3.7 Global Defibrinated Horse Blood Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Defibrinated Horse Blood Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Defibrinated Horse Blood Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Defibrinated Horse Blood Tier 1, Tier 2, and Tier 3
4 Defibrinated Horse Blood Regional Status and Outlook
  1. 4.1 Global Defibrinated Horse Blood Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Defibrinated Horse Blood Historic Market Size by Region
  3. 4.2.1 Global Defibrinated Horse Blood Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Defibrinated Horse Blood Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Defibrinated Horse Blood Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Defibrinated Horse Blood Forecasted Market Size by Region
  7. 4.3.1 Global Defibrinated Horse Blood Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Defibrinated Horse Blood Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Defibrinated Horse Blood Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Defibrinated Horse Blood by Application
  1. 5.1 Defibrinated Horse Blood Market by Application
  2. 5.1.1 Biomedicine
  3. 5.1.2 Research
  4. 5.2 Global Defibrinated Horse Blood Market Size by Application
  5. 5.2.1 Global Defibrinated Horse Blood Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Defibrinated Horse Blood Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Defibrinated Horse Blood Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Defibrinated Horse Blood Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Defibrinated Horse Blood Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Defibrinated Horse Blood Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Defibrinated Horse Blood Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Defibrinated Horse Blood Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Defibrinated Horse Blood Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 TCS Biosciences
  8. 6.2.1 TCS Biosciences Company Information
  9. 6.2.2 TCS Biosciences Business Overview
  10. 6.2.3 TCS Biosciences Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 TCS Biosciences Defibrinated Horse Blood Product Portfolio
  12. 6.2.5 TCS Biosciences Recent Developments
  13. 6.3 BioMérieux
  14. 6.3.1 BioMérieux Company Information
  15. 6.3.2 BioMérieux Business Overview
  16. 6.3.3 BioMérieux Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 BioMérieux Defibrinated Horse Blood Product Portfolio
  18. 6.3.5 BioMérieux Recent Developments
  19. 6.4 E & O Laboratories Ltd
  20. 6.4.1 E & O Laboratories Ltd Company Information
  21. 6.4.2 E & O Laboratories Ltd Business Overview
  22. 6.4.3 E & O Laboratories Ltd Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 E & O Laboratories Ltd Defibrinated Horse Blood Product Portfolio
  24. 6.4.5 E & O Laboratories Ltd Recent Developments
  25. 6.5 Southern Biological
  26. 6.5.1 Southern Biological Company Information
  27. 6.5.2 Southern Biological Business Overview
  28. 6.5.3 Southern Biological Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Southern Biological Defibrinated Horse Blood Product Portfolio
  30. 6.5.5 Southern Biological Recent Developments
  31. 6.6 Biowest(BioNordic A/S)
  32. 6.6.1 Biowest(BioNordic A/S) Company Information
  33. 6.6.2 Biowest(BioNordic A/S) Business Overview
  34. 6.6.3 Biowest(BioNordic A/S) Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Biowest(BioNordic A/S) Defibrinated Horse Blood Product Portfolio
  36. 6.6.5 Biowest(BioNordic A/S) Recent Developments
  37. 6.7 Pel-Freez Biologicals
  38. 6.7.1 Pel-Freez Biologicals Company Information
  39. 6.7.2 Pel-Freez Biologicals Business Overview
  40. 6.7.3 Pel-Freez Biologicals Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pel-Freez Biologicals Defibrinated Horse Blood Product Portfolio
  42. 6.7.5 Pel-Freez Biologicals Recent Developments
  43. 6.8 Trafalgar Scientific
  44. 6.8.1 Trafalgar Scientific Company Information
  45. 6.8.2 Trafalgar Scientific Business Overview
  46. 6.8.3 Trafalgar Scientific Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Trafalgar Scientific Defibrinated Horse Blood Product Portfolio
  48. 6.8.5 Trafalgar Scientific Recent Developments
  49. 6.9 HemoStat Laboratories
  50. 6.9.1 HemoStat Laboratories Company Information
  51. 6.9.2 HemoStat Laboratories Business Overview
  52. 6.9.3 HemoStat Laboratories Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 HemoStat Laboratories Defibrinated Horse Blood Product Portfolio
  54. 6.9.5 HemoStat Laboratories Recent Developments
  55. 6.10 EWC Diagnostics
  56. 6.10.1 EWC Diagnostics Company Information
  57. 6.10.2 EWC Diagnostics Business Overview
  58. 6.10.3 EWC Diagnostics Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 EWC Diagnostics Defibrinated Horse Blood Product Portfolio
  60. 6.10.5 EWC Diagnostics Recent Developments
  61. 6.11 Dutscher
  62. 6.11.1 Dutscher Company Information
  63. 6.11.2 Dutscher Business Overview
  64. 6.11.3 Dutscher Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Dutscher Defibrinated Horse Blood Product Portfolio
  66. 6.11.5 Dutscher Recent Developments
  67. 6.12 Serana Europe
  68. 6.12.1 Serana Europe Company Information
  69. 6.12.2 Serana Europe Business Overview
  70. 6.12.3 Serana Europe Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Serana Europe Defibrinated Horse Blood Product Portfolio
  72. 6.12.5 Serana Europe Recent Developments
  73. 6.13 Kraeber & Co. GmbH
  74. 6.13.1 Kraeber & Co. GmbH Company Information
  75. 6.13.2 Kraeber & Co. GmbH Business Overview
  76. 6.13.3 Kraeber & Co. GmbH Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Kraeber & Co. GmbH Defibrinated Horse Blood Product Portfolio
  78. 6.13.5 Kraeber & Co. GmbH Recent Developments
  79. 6.14 Bio Nutrientes Do Brasil Ltda.
  80. 6.14.1 Bio Nutrientes Do Brasil Ltda. Company Information
  81. 6.14.2 Bio Nutrientes Do Brasil Ltda. Business Overview
  82. 6.14.3 Bio Nutrientes Do Brasil Ltda. Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bio Nutrientes Do Brasil Ltda. Defibrinated Horse Blood Product Portfolio
  84. 6.14.5 Bio Nutrientes Do Brasil Ltda. Recent Developments
  85. 6.15 Lampire Biological Laboratories, Inc.
  86. 6.15.1 Lampire Biological Laboratories, Inc. Company Information
  87. 6.15.2 Lampire Biological Laboratories, Inc. Business Overview
  88. 6.15.3 Lampire Biological Laboratories, Inc. Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Lampire Biological Laboratories, Inc. Defibrinated Horse Blood Product Portfolio
  90. 6.15.5 Lampire Biological Laboratories, Inc. Recent Developments
  91. 6.16 Innovative Research Inc
  92. 6.16.1 Innovative Research Inc Company Information
  93. 6.16.2 Innovative Research Inc Business Overview
  94. 6.16.3 Innovative Research Inc Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Innovative Research Inc Defibrinated Horse Blood Product Portfolio
  96. 6.16.5 Innovative Research Inc Recent Developments
  97. 6.17 Colorado Serum
  98. 6.17.1 Colorado Serum Company Information
  99. 6.17.2 Colorado Serum Business Overview
  100. 6.17.3 Colorado Serum Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Colorado Serum Defibrinated Horse Blood Product Portfolio
  102. 6.17.5 Colorado Serum Recent Developments
  103. 6.18 SSI Diagnostica
  104. 6.18.1 SSI Diagnostica Company Information
  105. 6.18.2 SSI Diagnostica Business Overview
  106. 6.18.3 SSI Diagnostica Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 SSI Diagnostica Defibrinated Horse Blood Product Portfolio
  108. 6.18.5 SSI Diagnostica Recent Developments
  109. 6.19 SR Group
  110. 6.19.1 SR Group Company Information
  111. 6.19.2 SR Group Business Overview
  112. 6.19.3 SR Group Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 SR Group Defibrinated Horse Blood Product Portfolio
  114. 6.19.5 SR Group Recent Developments
  115. 6.20 Szabo-Scandic
  116. 6.20.1 Szabo-Scandic Company Information
  117. 6.20.2 Szabo-Scandic Business Overview
  118. 6.20.3 Szabo-Scandic Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Szabo-Scandic Defibrinated Horse Blood Product Portfolio
  120. 6.20.5 Szabo-Scandic Recent Developments
  121. 6.21 Rockland Immunochemicals, Inc.
  122. 6.21.1 Rockland Immunochemicals, Inc. Company Information
  123. 6.21.2 Rockland Immunochemicals, Inc. Business Overview
  124. 6.21.3 Rockland Immunochemicals, Inc. Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Rockland Immunochemicals, Inc. Defibrinated Horse Blood Product Portfolio
  126. 6.21.5 Rockland Immunochemicals, Inc. Recent Developments
  127. 6.22 LABone Scientific Co.Ltd.
  128. 6.22.1 LABone Scientific Co.Ltd. Company Information
  129. 6.22.2 LABone Scientific Co.Ltd. Business Overview
  130. 6.22.3 LABone Scientific Co.Ltd. Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 LABone Scientific Co.Ltd. Defibrinated Horse Blood Product Portfolio
  132. 6.22.5 LABone Scientific Co.Ltd. Recent Developments
  133. 6.23 Quad Five(Materials Bio Inc.)
  134. 6.23.1 Quad Five(Materials Bio Inc.) Company Information
  135. 6.23.2 Quad Five(Materials Bio Inc.) Business Overview
  136. 6.23.3 Quad Five(Materials Bio Inc.) Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Quad Five(Materials Bio Inc.) Defibrinated Horse Blood Product Portfolio
  138. 6.23.5 Quad Five(Materials Bio Inc.) Recent Developments
  139. 6.24 Guangzhou Ruite Biotechnology Co., Ltd.
  140. 6.24.1 Guangzhou Ruite Biotechnology Co., Ltd. Company Information
  141. 6.24.2 Guangzhou Ruite Biotechnology Co., Ltd. Business Overview
  142. 6.24.3 Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Horse Blood Product Portfolio
  144. 6.24.5 Guangzhou Ruite Biotechnology Co., Ltd. Recent Developments
  145. 6.25 Obio Technology (Shanghai) Corp., Ltd.
  146. 6.25.1 Obio Technology (Shanghai) Corp., Ltd. Company Information
  147. 6.25.2 Obio Technology (Shanghai) Corp., Ltd. Business Overview
  148. 6.25.3 Obio Technology (Shanghai) Corp., Ltd. Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Obio Technology (Shanghai) Corp., Ltd. Defibrinated Horse Blood Product Portfolio
  150. 6.25.5 Obio Technology (Shanghai) Corp., Ltd. Recent Developments
  151. 6.26 Beijing Solarbio Science & Technology Co.,Ltd.
  152. 6.26.1 Beijing Solarbio Science & Technology Co.,Ltd. Company Information
  153. 6.26.2 Beijing Solarbio Science & Technology Co.,Ltd. Business Overview
  154. 6.26.3 Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Horse Blood Product Portfolio
  156. 6.26.5 Beijing Solarbio Science & Technology Co.,Ltd. Recent Developments
  157. 6.27 Nanjing SenBeiJia Biological Technology Co., Ltd.
  158. 6.27.1 Nanjing SenBeiJia Biological Technology Co., Ltd. Company Information
  159. 6.27.2 Nanjing SenBeiJia Biological Technology Co., Ltd. Business Overview
  160. 6.27.3 Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Horse Blood Sales, Revenue and Gross Margin (2021-2026)
  161. 6.27.4 Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Horse Blood Product Portfolio
  162. 6.27.5 Nanjing SenBeiJia Biological Technology Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Defibrinated Horse Blood Sales by Country
  2. 7.1.1 North America Defibrinated Horse Blood Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Defibrinated Horse Blood Sales by Country (2021-2026)
  4. 7.1.3 North America Defibrinated Horse Blood Sales Forecast by Country (2027-2032)
  5. 7.2 North America Defibrinated Horse Blood Market Size by Country
  6. 7.2.1 North America Defibrinated Horse Blood Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Defibrinated Horse Blood Market Size by Country (2021-2026)
  8. 7.2.3 North America Defibrinated Horse Blood Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Defibrinated Horse Blood Sales by Country
  2. 8.1.1 Europe Defibrinated Horse Blood Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Defibrinated Horse Blood Sales by Country (2021-2026)
  4. 8.1.3 Europe Defibrinated Horse Blood Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Defibrinated Horse Blood Market Size by Country
  6. 8.2.1 Europe Defibrinated Horse Blood Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Defibrinated Horse Blood Market Size by Country (2021-2026)
  8. 8.2.3 Europe Defibrinated Horse Blood Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Defibrinated Horse Blood Sales by Country
  2. 9.1.1 Asia-Pacific Defibrinated Horse Blood Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Defibrinated Horse Blood Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Defibrinated Horse Blood Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Defibrinated Horse Blood Market Size by Country
  6. 9.2.1 Asia-Pacific Defibrinated Horse Blood Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Defibrinated Horse Blood Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Defibrinated Horse Blood Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Defibrinated Horse Blood Sales by Country
  2. 10.1.1 South America Defibrinated Horse Blood Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Defibrinated Horse Blood Sales by Country (2021-2026)
  4. 10.1.3 South America Defibrinated Horse Blood Sales Forecast by Country (2027-2032)
  5. 10.2 South America Defibrinated Horse Blood Market Size by Country
  6. 10.2.1 South America Defibrinated Horse Blood Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Defibrinated Horse Blood Market Size by Country (2021-2026)
  8. 10.2.3 South America Defibrinated Horse Blood Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Defibrinated Horse Blood Sales by Country
  2. 11.1.1 Middle East and Africa Defibrinated Horse Blood Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Defibrinated Horse Blood Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Defibrinated Horse Blood Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Defibrinated Horse Blood Market Size by Country
  6. 11.2.1 Middle East and Africa Defibrinated Horse Blood Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Defibrinated Horse Blood Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Defibrinated Horse Blood Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Defibrinated Horse Blood Value Chain Analysis
  2. 12.1.1 Defibrinated Horse Blood Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Defibrinated Horse Blood Production Mode & Process
  7. 12.2 Defibrinated Horse Blood Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Defibrinated Horse Blood Distributors
  10. 12.2.3 Defibrinated Horse Blood Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst